Genipin inhibits the growth of human bladder cancer cells via inactivation of PI3K/Akt signaling

Li,Zheng; Zhang,Tian‑Biao; Jia,Dong‑Hui; Sun,Wen‑Qi; Wang,Chao‑Liang; Gu,Ao‑Zheng; Yang,Xiao‑Ming

doi:10.3892/ol.2017.7588

Genipin inhibits the growth of human bladder cancer cells via inactivation of PI3K/Akt signaling

Authors:
- Zheng Li
- Tian‑Biao Zhang
- Dong‑Hui Jia
- Wen‑Qi Sun
- Chao‑Liang Wang
- Ao‑Zheng Gu
- Xiao‑Ming Yang
View Affiliations

Affiliations: Department of Urology, Nanyang City Center Hospital, Nanyang, Henan 473009, P.R. China, Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, P.R. China
Published online on: December 11, 2017 https://doi.org/10.3892/ol.2017.7588
Pages: 2619-2624

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Genipin, a natural compound derived from the fruit of Gardenia jasminoides, possesses numerous biological properties. The aim of the present study was to investigate the anticancer effects of genipin in human bladder cancer. T24 and 5637 bladder cancer cells were treated with different concentrations of genipin (0‑200 µM) and tested for cell viability, colony formation, cell cycle progression and apoptosis. A xenograft model of bladder cancer was established to determine the anticancer effect of genipin in vivo. The involvement of the phosphoinositide‑3 kinase (PI3K)/Akt pathway in the action of genipin was examined. Genipin treatment significantly inhibited the viability and clonogenic growth of bladder cancer cells and inhibited the growth of T24 xenograft tumors, compared with vehicle controls (P<0.05). Genipin‑treated cells exhibited a cell cycle arrest at the G0/G1‑phase, which was accompanied by a deregulation of numerous cell cycle regulators. Genipin‑treated cells demonstrated a significant increase in the percentage of apoptotic cells, loss of mitochondrial membrane potential, Bax translocation to the mitochondria and the release of cytochrome c to the cytosol. Additionally, genipin treatment significantly (P<0.05) reduced the phosphorylation levels of PI3K and Akt in bladder cancer cells. Importantly, genipin‑mediated anticancer effects were reversed by the overexpression of constitutively active Akt. In conclusion, to the best of our knowledge, the present study demonstrates for the first time the growth inhibitory effects of genipin in bladder cancer cells, and indicates its potential as a natural anticancer agent for bladder cancer.

View Figures

View References

1	Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, Kassouf W, Kiemeney LA, La Vecchia C, Shariat S and Lotan Y: Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 63:234–241. 2013. View Article : Google Scholar : PubMed/NCBI
2	Mahdavifar N, Ghoncheh M, Pakzad R, Momenimovahed Z and Salehiniya H: Epidemiology, incidence and mortality of bladder cancer and their relationship with the development index in the world. Asian Pac J Cancer Prev. 17:381–386. 2016. View Article : Google Scholar : PubMed/NCBI
3	Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015. View Article : Google Scholar : PubMed/NCBI
4	Li S, Zeng XT, Ruan XL, Wang XH, Guo Y and Yang ZH: Simultaneous transurethral resection of bladder cancer and prostate may reduce recurrence rates: A systematic review and meta-analysis. Exp Ther Med. 4:685–692. 2012. View Article : Google Scholar : PubMed/NCBI
5	Vinall RL, Tepper CG, Ripoll AA, Gandour-Edwards RF, Durbin-Johnson BP, Yap SA, Ghosh PM and deVere White RW: Decreased expression of let-7c is associated with non-response of muscle-invasive bladder cancer patients to neoadjuvant chemotherapy. Genes Cancer. 7:86–97. 2016.PubMed/NCBI
6	Cirone P, Andresen CJ, Eswaraka JR, Lappin PB and Bagi CM: Patient-derived xenografts reveal limits to PI3K/mTOR-and MEK-mediated inhibition of bladder cancer. Cancer Chemother Pharmacol. 73:525–538. 2014. View Article : Google Scholar : PubMed/NCBI
7	Wang Y, Leng H, Chen H, Wang L, Jiang N, Huo X and Yu B: Knockdown of UBE2T inhibits osteosarcoma cell proliferation, migration, and invasion by suppressing the PI3K/Akt signaling pathway. Oncol Res. 24:361–369. 2016. View Article : Google Scholar : PubMed/NCBI
8	Dong Q, Fu L, Zhao Y, Tan S and Wang E: Derlin-1 overexpression confers poor prognosis in muscle invasive bladder cancer and contributes to chemoresistance and invasion through PI3K/AKT and ERK/MMP signaling. Oncotarget. 8:17059–17069. 2017.PubMed/NCBI
9	Alayev A, Salamon RS, Schwartz NS, Berman AY, Wiener SL and Holz MK: Combination of rapamycin and resveratrol for treatment of bladder cancer. J Cell Physiol. 232:436–446. 2017. View Article : Google Scholar : PubMed/NCBI
10	Nam KN, Choi YS, Jung HJ, Park GH, Park JM, Moon SK, Cho KH, Kang C, Kang I, Oh MS and Lee EH: Genipin inhibits the inflammatory response of rat brain microglial cells. Int Immunopharmacol. 10:493–499. 2010. View Article : Google Scholar : PubMed/NCBI
11	Wang GF, Wu SY, Rao JJ, Lü L, Xu W, Pang JX, Liu ZQ, Wu SG and Zhang JJ: Genipin inhibits endothelial exocytosis via nitric oxide in cultured human umbilical vein endothelial cells. Acta Pharmacol Sin. 30:589–596. 2009. View Article : Google Scholar : PubMed/NCBI
12	Zhang CY, Parton LE, Ye CP, Krauss S, Shen R, Lin CT, Porco JA Jr and Lowell BB: Genipin inhibits UCP2-mediated proton leak and acutely reverses obesity- and high glucose-induced beta cell dysfunction in isolated pancreatic islets. Cell Metab. 3:417–427. 2006. View Article : Google Scholar : PubMed/NCBI
13	Suzuki Y, Kondo K, Ikeda Y and Umemura K: Antithrombotic effect of geniposide and genipin in the mouse thrombosis model. Planta Med. 67:807–810. 2001. View Article : Google Scholar : PubMed/NCBI
14	Hughes RH, Silva VA, Ahmed I, Shreiber DI and Morrison B III: Neuroprotection by genipin against reactive oxygen and reactive nitrogen species-mediated injury in organotypic hippocampal slice cultures. Brain Res. 1543:308–314. 2014. View Article : Google Scholar : PubMed/NCBI
15	Wang N, Zhu M, Tsao SW, Man K, Zhang Z and Feng Y: Up-regulation of TIMP-1 by genipin inhibits MMP-2 activities and suppresses the metastatic potential of human hepatocellular carcinoma. PLoS One. 7:e463182012. View Article : Google Scholar : PubMed/NCBI
16	Wang R, MoYung KC, Zhao YJ and Poon K: A mechanism for the temporal potentiation of genipin to the cytotoxicity of cisplatin in colon cancer cells. Int J Med Sci. 13:507–516. 2016. View Article : Google Scholar : PubMed/NCBI
17	Perelman A, Wachtel C, Cohen M, Haupt S, Shapiro H and Tzur A: JC-1: Alternative excitation wavelengths facilitate mitochondrial membrane potential cytometry. Cell Death Dis. 3:e4302012. View Article : Google Scholar : PubMed/NCBI
18	Singh AN, Baruah MM and Sharma N: Structure Based docking studies towards exploring potential anti-androgen activity of selected phytochemicals against Prostate Cancer. Sci Rep. 7:19552017. View Article : Google Scholar : PubMed/NCBI
19	Koo HJ, Song YS, Kim HJ, Lee YH, Hong SM, Kim SJ, Kim BC, Jin C, Lim CJ and Park EH: Antiinflammatory effects of genipin, an active principle of gardenia. Eur J Pharmacol. 495:201–208. 2004. View Article : Google Scholar : PubMed/NCBI
20	Cao H, Feng Q, Xu W, Li X, Kang Z, Ren Y and Du L: Genipin induced apoptosis associated with activation of the c-Jun NH2-terminal kinase and p53 protein in HeLa cells. Biol Pharm Bull. 33:1343–1348. 2010. View Article : Google Scholar : PubMed/NCBI
21	Ko H, Kim JM, Kim SJ, Shim SH, Ha CH and Chang HI: Induction of apoptosis by genipin inhibits cell proliferation in AGS human gastric cancer cells via Egr1/p21 signaling pathway. Bioorg Med Chem Lett. 25:4191–4196. 2015. View Article : Google Scholar : PubMed/NCBI
22	Feng Q, Cao HL, Xu W, Li XR, Ren YQ and Du LF: Apoptosis induced by genipin in human leukemia K562 cells: Involvement of c-Jun N-terminal kinase in G2/M arrest. Acta Pharmacol Sin. 32:519–527. 2011. View Article : Google Scholar : PubMed/NCBI
23	Coqueret O: New roles for p21 and p27 cell-cycle inhibitors: A function for each cell compartment? Trends Cell Biol. 13:65–70. 2003. View Article : Google Scholar : PubMed/NCBI
24	Pastorino JG, Chen ST, Tafani M, Snyder JW and Farber JL: The overexpression of bax produces cell death upon induction of the mitochondrial permeability transition. J Biol Chem. 273:7770–7775. 1998. View Article : Google Scholar : PubMed/NCBI
25	Yang X, Yao J, Luo Y, Han Y, Wang Z and Du L: P38 MAP kinase mediates apoptosis after genipin treatment in non-small-cell lung cancer H1299 cells via a mitochondrial apoptotic cascade. J Pharmacol Sci. 121:272–281. 2013. View Article : Google Scholar : PubMed/NCBI
26	Qin J, Xie LP, Zheng XY, Wang YB, Bai Y, Shen HF, Li LC and Dahiya R: A component of green tea, (−)-epigallocatechin-3-gallate, promotes apoptosis in T24 human bladder cancer cells via modulation of the PI3K/Akt pathway and Bcl-2 family proteins. Biochem Biophys Res Commun. 354:852–857. 2007. View Article : Google Scholar : PubMed/NCBI
27	Kim MS, Kim JE, Lim DY, Huang Z, Chen H, Langfald A, Lubet RA, Grubbs CJ, Dong Z and Bode AM: Naproxen induces cell-cycle arrest and apoptosis in human urinary bladder cancer cell lines and chemically induced cancers by targeting PI3K. Cancer Prev Res (Phila). 7:236–245. 2014. View Article : Google Scholar : PubMed/NCBI